Prometheus Biosciences, Inc., (RXDX) Social Stream
Warning: This security is no longer trading.
Roche has completed deal to acquire Ignyta, Inc.
Featured Post From StockTwits About RXDX
$RXDX New SEC Filing: 8-K Other Events - Prometheus Biosciences, Inc. (0001718852) August 04MarketNewswire, published August 5, 2021
Item 8.01. Other Events. On August 4, 2021, Tadataka Yamada, M.D., the Chairman of Prometheus Biosciences, Inc.'s Board of Directors (the "Board"), Chair of the Nominating & Corporate Governance Committee of the Board and a member of the Compensation Committee of the Board, passed away unexpectedly. Dr. Yamada served as a member of the Board since 2018 and will be greatly missed. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PROMETHEUS BIOSCIENCES, INC. Date: August 5, 2021 By: /s/ Timothy K. Andrews Timothy K. Andrews General Counsel and Secret (...)
https://mkn.re/90245
Loading social stream, please wait...